BNP Paribas Financial Markets’s CorMedix CRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $121K | Sell |
17,833
-97
| -0.5% | -$717 | ﹤0.01% | 4278 |
|
|
2025
Q4 | $209K | Sell |
17,930
-18,051
| -50% | -$200K | ﹤0.01% | 4039 |
|
|
2025
Q3 | $418K | Sell |
35,981
-32,434
| -47% | -$392K | ﹤0.01% | 3640 |
|
|
2025
Q2 | $843K | Buy |
68,415
+55,997
| +451% | +$618K | ﹤0.01% | 3018 |
|
|
2025
Q1 | $76.5K | Buy |
12,418
+4,423
| +55% | +$45.8K | ﹤0.01% | 4138 |
|
|
2024
Q4 | $64.8K | Sell |
7,995
-3,955
| -33% | -$39.5K | ﹤0.01% | 4325 |
|
|
2024
Q3 | $96.6K | Buy |
11,950
+6,761
| +130% | +$36.6K | ﹤0.01% | 3471 |
|
|
2024
Q2 | $22.5K | Sell |
5,189
-21,798
| -81% | -$111K | ﹤0.01% | 3626 |
|
|
2024
Q1 | $114K | Sell |
26,987
-49,638
| -65% | -$172K | ﹤0.01% | 3403 |
|
|
2023
Q4 | $288K | Buy |
76,625
+45,483
| +146% | +$157K | ﹤0.01% | 3082 |
|
|
2023
Q3 | $115K | Buy |
31,142
+18,958
| +156% | +$75.4K | ﹤0.01% | 3287 |
|
|
2023
Q2 | $48.3K | Buy |
12,184
+11,624
| +2,076% | +$57.5K | ﹤0.01% | 3482 |
|
|
2023
Q1 | $2.32K | Sell |
560
-91
| -14% | -$372 | ﹤0.01% | 3627 |
|
|
2022
Q4 | $2.75K | Sell |
651
-17
| -3% | -$60 | ﹤0.01% | 3709 |
|
|
2022
Q3 | $1.89K | Sell |
668
-16,971
| -96% | -$70.6K | ﹤0.01% | 4353 |
|
|
2022
Q2 | $70.9K | Buy |
17,639
+11,355
| +181% | +$42.2K | ﹤0.01% | 3462 |
|
|
2022
Q1 | $34.4K | Sell |
6,284
-8,362
| -57% | -$38.3K | ﹤0.01% | 3628 |
|
|
2021
Q4 | $66.6K | Buy |
14,646
+5,580
| +62% | +$27.7K | ﹤0.01% | 3688 |
|
|
2021
Q3 | $42.2K | Buy |
9,066
+5,785
| +176% | +$33.7K | ﹤0.01% | 3556 |
|
|
2021
Q2 | $22.5K | Sell |
3,281
-642
| -16% | -$5.11K | ﹤0.01% | 3502 |
|
|
2021
Q1 | $39.2K | Sell |
3,923
-1,525
| -28% | -$16.1K | ﹤0.01% | 3662 |
|
|
2020
Q4 | $40.5K | Sell |
5,448
-959
| -15% | -$6.52K | ﹤0.01% | 3647 |
|
|
2020
Q3 | $38.6K | Buy |
6,407
+5,504
| +610% | +$27.6K | ﹤0.01% | 3584 |
|
|
2020
Q2 | $5.69K | Sell |
903
-6,978
| -89% | -$32.3K | ﹤0.01% | 3955 |
|
|
2020
Q1 | $28.3K | Buy |
7,881
+4,232
| +116% | +$23.9K | ﹤0.01% | 3803 |
|
|
2019
Q4 | $26.6K | Buy |
3,649
+654
| +22% | +$4K | ﹤0.01% | 3924 |
|
|
2019
Q3 | $19.1K | Buy |
2,995
+2,929
| +4,438% | +$24.6K | ﹤0.01% | 3965 |
|
|
2019
Q2 | $592 | Buy |
+66
| New | +$518 | ﹤0.01% | 4395 |
|
|
2019
Q1 | – | Sell |
-5
| Closed | -$30 | – | 4306 |
|
|
2018
Q4 | $30 | Hold |
5
| – | – | ﹤0.01% | 4269 |
|
|
2018
Q3 | $22 | Hold |
5
| – | – | ﹤0.01% | 4399 |
|
|
2018
Q2 | $5 | Hold |
5
| – | – | ﹤0.01% | 4400 |
|
|
2018
Q1 | $4 | Hold |
5
| – | – | ﹤0.01% | 4208 |
|
|
2017
Q4 | $12 | Hold |
5
| – | – | ﹤0.01% | 4193 |
|
|
2017
Q3 | $12 | Hold |
5
| – | – | ﹤0.01% | 4208 |
|
|
2017
Q2 | $10 | Hold |
5
| – | – | ﹤0.01% | 4229 |
|
|
2017
Q1 | $37 | Hold |
5
| – | – | ﹤0.01% | 4037 |
|
|
2016
Q4 | $35 | Hold |
5
| – | – | ﹤0.01% | 4131 |
|
|
2016
Q3 | $58 | Hold |
5
| – | – | ﹤0.01% | 3510 |
|
|
2016
Q2 | $46 | Buy |
+5
| New | +$76 | ﹤0.01% | 3530 |
|
|
2016
Q1 | – | Sell |
-1,862
| Closed | -$18.9K | – | 2754 |
|
|
2015
Q4 | $18.9K | Buy |
1,862
+275
| +17% | +$3.17K | ﹤0.01% | 3303 |
|
|
2015
Q3 | $15.8K | Buy |
1,587
+1,070
| +207% | +$16.5K | ﹤0.01% | 3358 |
|
|
2015
Q2 | $10K | Buy |
+517
| New | +$17.7K | ﹤0.01% | 3339 |
|
Other funds holding CRMD
DTC
VCM
RA
OAM
VPM
BNP Paribas Financial Markets's CRMD Position: Q1 2026 in Review
BNP Paribas Financial Markets reduced its CorMedix (CRMD) stake by 0.54% in Q1 2026, selling an estimated $717 and leaving 17,833 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #4278.
BNP Paribas Financial Markets first reported a position in CRMD in Q2 2015 and has held it in 42 quarters since. The position peaked at $843K in Q2 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.
- BNP Paribas Financial Markets held 17,833 shares of CorMedix worth $121K as of Q1 2026.
- BNP Paribas Financial Markets sold 97 CorMedix shares in Q1 2026, an estimated $717.
- CorMedix made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4278 holding.
- BNP Paribas Financial Markets first reported a position in CorMedix in Q2 2015 and has held it in 42 quarters since.
- BNP Paribas Financial Markets's CorMedix position peaked at $843K in Q2 2025.
- 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.